Zobrazeno 1 - 10
of 188
pro vyhledávání: '"Lin ZH"'
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 9, Iss 1, Pp 1-17 (2024)
Abstract Background Recent advancements in positron emission tomograph (PET) using prostate specific membrane antigen (PSMA)-targeted radiopharmaceuticals have changed the standard of care for prostate cancer patients by providing more accurate infor
Externí odkaz:
https://doaj.org/article/c68203cee7834f80a54764d3e4f6a5e3
Autor:
Lin Zhou, Yicong Wan, Lin Zhang, Huangyang Meng, Lin Yuan, Shulin Zhou, Wenjun Cheng, Yi Jiang
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 175, Iss , Pp 116733- (2024)
The introduction of PARP inhibitors (PARPis) and immune checkpoint inhibitors (ICIs) has marked a significant shift in the treatment landscape for solid tumors. Emerging preclinical evidence and initial clinical trials have indicated that the synergi
Externí odkaz:
https://doaj.org/article/0c573b5b720547b7918ed471afe50407
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundPain is a complex perception involving unpleasant somatosensory and emotional experiences. However, the underlying mechanisms that mediate its different components remain unclear. Sphingosine-1-phosphate (S1P), a metabolite of sphingomyelin
Externí odkaz:
https://doaj.org/article/4ed8aa86b88e49b597df966c1768e72a
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 176, Iss , Pp 116856- (2024)
Fibromyalgia is characterised by widespread chronic pain and is often accompanied by comorbidities such as sleep disorders, anxiety, and depression. Because it is often accompanied by many adverse symptoms and lack of effective treatment, it is impor
Externí odkaz:
https://doaj.org/article/aacf644ed05548549fe8e1fdfe7afa36
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 176, Iss , Pp 116848- (2024)
Liver fibrosis is an intrahepatic chronic damage repair response caused by various reasons such as alcoholic liver, fatty liver, viral hepatitis, autoimmune diseases, etc., and is closely related to the progression of liver disease. Currently, the me
Externí odkaz:
https://doaj.org/article/d0e33918cc2b49d29e310f77b40d86e2
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundPolatuzumab vedotin, the first FDA-approved antibody-drug conjugate (ADC) targeting CD79b, is utilized in the treatment of previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL), as well as relapsed
Externí odkaz:
https://doaj.org/article/8ee67c8af8764e5fb08c2512c0d2b031
Autor:
Lin Zhang, Han Li, Lihan Hu, Xiangqin Ou, Hanzhi Tan, Xuanqi Zhang, Chung Tai Lau, Aiping Lyu, Zhaoxiang Bian, Xuan Zhang
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
ObjectivesThe impact of the Standard Protocol Items: Recommendations for Interventional Trials of Traditional Chinese Medicine (SPIRIT-TCM) Extension 2018 statement on the reporting quality of randomized controlled trial (RCT) protocols in traditiona
Externí odkaz:
https://doaj.org/article/c2b8971e34c44b4eb14f3a30f53cb038
Autor:
Xiaoqi Liu, Hai Xiao, Mingxia Luo, Junpeng Meng, Lin Zhong, Tao Wu, Yongxia Zhao, Faming Wu, Jian Xie
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Introduction:P. candolleana Wight et Arn. Is a traditional Chinese herbal medicine used by the Gelao nationality in southwest China, has been historically applied to treat various gastrointestinal disorders. Despite its traditional usage, scientific
Externí odkaz:
https://doaj.org/article/c30c44e5db8e4e6c8442c6ea6c333379
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 173, Iss , Pp 116377- (2024)
Glycogen synthase kinase-3(GSK-3) is a protein kinase that can phosphorylate over a hundred substrates and regulate cell differentiation, proliferation, and death. Researchers have acknowledged the pivotal role of abnormal activation of GSK-3 in the
Externí odkaz:
https://doaj.org/article/7864f88ae30b4a71b8f7d29826547dbe
Autor:
Bo Chen, Xinqian Dong, Jin Long Zhang, Xitong Sun, Lin Zhou, Kangning Zhao, Hualiang Deng, Zhen Sun
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Ulcerative colitis (UC) is a nonspecific inflammatory bowel disease characterized by abdominal pain, bloody diarrhea, weight loss, and colon shortening. However, UC is difficult to cure due to its high drug resistance rate and easy recurrence. Moreov
Externí odkaz:
https://doaj.org/article/7221c888ad484759a54afaae28df98ac